Ye Weiguo Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
2
Insider Sells Sum
$194,772.80

Insider Activity of Ye Weiguo

According to the SEC Form 4 filings, Ye Weiguo, being in a position of

  1. Chief Operating Officer at Gyre Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 128014 shares for $812,138,
    over all time since 2026-05-14, has bought 0 shares, and sold 128014 shares for $812,138.

Biography of Ye Weiguo

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $812,13815100

Comparison of Insiders on Amount of Buys and Sells

2026-06-18SaleGyre Therapeutics, Inc.
GYRE
Chief Operating Officer
3,000
0.0031%
$6.35$19,050+5.44%
2026-06-11SaleGyre Therapeutics, Inc.
GYRE
Chief Operating Officer
2,800
0.0029%
$6.17$17,276+8.09%
2026-06-10SaleGyre Therapeutics, Inc.
GYRE
Chief Operating Officer
5,000
0.0054%
$6.24$31,200+9.92%
2026-06-10SaleGyre Therapeutics, Inc.
GYRE
Chief Operating Officer
6,418
0.0069%
$6.21$39,856+9.92%
2026-06-09SaleGyre Therapeutics, Inc.
GYRE
Chief Operating Officer
3,000
0.0031%
$6.15$18,450+6.61%
2026-06-09SaleGyre Therapeutics, Inc.
GYRE
Chief Operating Officer
14,500
0.015%
$6.14$89,030+6.61%
2026-06-05SaleGyre Therapeutics, Inc.
GYRE
Chief Operating Officer
15,401
0.0162%
$6.40$98,566+3.74%
2026-06-04SaleGyre Therapeutics, Inc.
GYRE
Chief Operating Officer
19,575
0.02%
$6.13$119,995+5.33%
2026-05-26SaleGyre Therapeutics, Inc.
GYRE
Chief Operating Officer
4,000
0.0042%
$6.10$24,400+8.92%
2026-05-22SaleGyre Therapeutics, Inc.
GYRE
Chief Operating Officer
3,500
0.0036%
$6.08$21,280+6.77%
2026-05-21SaleGyre Therapeutics, Inc.
GYRE
Chief Operating Officer
12,820
0.0132%
$6.15$78,843+4.53%
2026-05-19SaleGyre Therapeutics, Inc.
GYRE
Chief Operating Officer
9,120
0.0096%
$6.37$58,094+2.96%
2026-05-18SaleGyre Therapeutics, Inc.
GYRE
Chief Operating Officer
200
0.0002%
$6.62$1,3240%
2026-05-15SaleGyre Therapeutics, Inc.
GYRE
Chief Operating Officer
13,100
0.0137%
$6.65$87,115-1.68%
2026-05-14SaleGyre Therapeutics, Inc.
GYRE
Chief Operating Officer
15,580
0.0159%
$6.91$107,658-8%
Total: 15
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.